Dashboard
Manage Tickers

EYPTEyePoint Pharmaceuticals, Inc.

Nasdaq eyepointpharma.com


$ 19.72 $ -0.20 (-1 %)    

Friday, 03-May-2024 15:59:47 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 19.74
$ 20.58
$ 0.00 x 0
$ 0.00 x 0
$ 19.71 - $ 21.25
$ 5.67 - $ 30.99
928,801
na
767.96M
$ 1.22
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-08-2024 12-31-2023 10-K
2 11-03-2023 09-30-2023 10-Q
3 08-04-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 03-10-2023 12-31-2022 10-K
6 11-04-2022 09-30-2022 10-Q
7 08-05-2022 06-30-2022 10-Q
8 05-06-2022 03-31-2022 10-Q
9 03-12-2022 12-31-2021 10-K
10 11-05-2021 09-30-2021 10-Q
11 08-06-2021 06-30-2021 10-Q
12 05-05-2021 03-31-2021 10-Q
13 03-12-2021 12-31-2020 10-K
14 11-06-2020 09-30-2020 10-Q
15 08-05-2020 06-30-2020 10-Q
16 05-08-2020 03-31-2020 10-Q
17 03-16-2020 12-31-2019 10-K
18 11-07-2019 09-30-2019 10-Q
19 08-07-2019 06-30-2019 10-Q
20 05-10-2019 03-31-2019 10-Q
21 11-09-2018 09-30-2018 10-Q
22 09-18-2018 06-30-2018 10-K
23 05-10-2018 03-31-2018 10-Q
24 02-08-2018 12-31-2017 10-Q
25 11-08-2017 09-30-2017 10-Q
26 09-13-2017 06-30-2017 10-K
27 05-08-2017 03-31-2017 10-Q
28 02-09-2017 12-31-2016 10-Q
29 11-08-2016 09-30-2016 10-Q
30 09-13-2016 06-30-2016 10-K
31 05-06-2016 03-31-2016 10-Q
32 02-09-2016 12-31-2015 10-Q
33 11-06-2015 09-30-2015 10-Q
34 09-10-2015 06-30-2015 10-K
35 05-08-2015 03-31-2015 10-Q
36 02-06-2015 12-31-2014 10-Q
37 11-07-2014 09-30-2014 10-Q
38 09-11-2014 06-30-2014 10-K
39 05-14-2014 03-31-2014 10-Q
40 02-12-2014 12-31-2013 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

over-10m-bet-on-this-healthcare-stock-check-out-these-4-stocks-insiders-are-buying
Over $10M Bet On This Healthcare Stock? Ch...
04/23/2024 12:22:51

critical-insights-from-eyepoint-pharmaceuticals-analyst-ratings-what-you-need-to-know
Critical Insights From EyePoint Pharmaceut...
03/08/2024 20:00:18

hc-wainwright--co-maintains-buy-on-eyepoint-pharmaceuticals-maintains-33-price-target
HC Wainwright & Co. Maintains Buy on EyePo...
03/08/2024 18:06:45

HC Wainwright & Co. analyst Yi Chen maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy and maintains $33 price ...

eyepoint-pharmaceuticals-expect-that-cash-cash-equivalents-and-investments-on-december-31-2023-of-331m-will-provide-cash-runway-through-planned-phase-3-trials-of-eyp-1901-for-wet-amd-in-2026
Eyepoint Pharmaceuticals Expect That Cash,...
03/07/2024 12:04:48

eyepoint-pharmaceuticals-q4-gaap-eps-033-beats-049-estimate-sales-1403m-beat-890m-estimate
EyePoint Pharmaceuticals Q4 GAAP EPS $(0.3...
03/07/2024 12:03:15

EyePoint Pharmaceuticals (NASDAQ:EYPT) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate...

earnings-scheduled-for-march-7-2024
Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

a-preview-of-eyepoint-pharmaceuticalss-earnings
A Preview Of EyePoint Pharmaceuticals's Ea...
03/06/2024 19:01:40

tesla-spirit-airlines-new-york-community-bancorp-and-other-big-stocks-moving-lower-on-monday
Tesla, Spirit Airlines, New York Community...
03/04/2024 15:40:18

U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.

mizuho-maintains-buy-on-eyepoint-pharmaceuticals-raises-price-target-to-39
Mizuho Maintains Buy on EyePoint Pharmaceu...
02/16/2024 23:48:24

Mizuho analyst Graig Suvannavejh maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy and raises the price target fro...

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
02/12/2024 17:35:25

eyepoint-pharmaceuticals-says-the-trial-met-its-primary-endpoint-with-both-eyp-1901-doses-demonstrating-statistical-non-inferiority-change-in-best-corrected-visual-acuity-the-trial-also-achieved-key-secondary-endpoint
EyePoint Pharmaceuticals Says The Trial Me...
02/04/2024 18:38:59

A second presentation also included the previously reported positive topline results of its Phase 2 DAVIO 2 trial of EYP-1901. ...

eyepoint-pharmaceuticals-announces-two-presentations-of-topline-data-with-additional-subgroup-analyses-from-the-phase-2-davio-2-clinical-trial-of-eyp-1901-for-the-treatment-of-wet-age-related-macular-degeneration
EyePoint Pharmaceuticals Announces Two Pre...
02/04/2024 18:37:27

Subgroup analyses underscore favorable clinical profile and durability of EYP-1901Presentations highlight previously reported p...

unveiling-7-analyst-insights-on-eyepoint-pharmaceuticals
Unveiling 7 Analyst Insights On EyePoint P...
01/22/2024 14:01:25

jp-morgan-initiates-coverage-on-eyepoint-pharmaceuticals-with-overweight-rating-announces-price-target-of-35
JP Morgan Initiates Coverage On EyePoint P...
01/22/2024 13:59:25

JP Morgan analyst Tessa Romero initiates coverage on EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Overweight rating and ann...

hc-wainwright--co-maintains-buy-on-eyepoint-pharmaceuticals-lowers-price-target-to-33
HC Wainwright & Co. Maintains Buy on EyePo...
01/16/2024 21:05:05

HC Wainwright & Co. analyst Yi Chen maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy and lowers the price tar...

30m-bet-on-this-healthcare-stock-check-out-these-3-stocks-insiders-are-buying
$30M Bet On This Healthcare Stock? Check O...
01/12/2024 11:38:48

Although U.S. stocks closed mixed on Thursday, there were a few notable insider trades.

form-4-shows-cormorant-global-healthcare-master-fund-lp-purchased-855000-shares-of-eyepoint-pharmaceuticals
Form 4 Shows Cormorant Global Healthcare M...
01/11/2024 21:09:13

eyepoint-says-first-patient-has-been-dosed-in-phase-2-verona-clinical-trial-of-eyp-1901-for-diabetic-macular-edema
EyePoint Says First Patient Has Been Dosed...
01/10/2024 12:04:23

EYP-1901 is an investigational sustained delivery therapy containing vorolanib, a selective tyrosine kinase inhibitor formulate...

russell-2000-rallies-to-16-month-highs-best-performing-small-cap-stocks-popping-over-80-in-december
Russell 2000 Rallies To 16-Month Highs: Be...
12/19/2023 22:05:47

Amidst fanfare for Nasdaq 100, U.S. small-cap stocks rally, with Russell 2000 index reaching levels not seen since Aug. 2022, 8...

10m-bet-on-this-healthcare-stock-check-out-these-4-stocks-insiders-are-buying
$10M Bet On This Healthcare Stock? Check O...
12/13/2023 12:04:47

Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION